• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • ACE Inhibitor
    10 Drugs classified under this drug class


    All the Drug Class Drugs

    Filter by letter: ALL A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    Aceril
    Dexcel
    RX
    full basket chart
    Aceril

    ACE Inhibitor. Captopril 12.5, 25, 50 mg.
    TABS: 90 x 12.5mg, 25mg, 50mg.
    Max. dly. dose: 150 mg. Hypertens: Initial: 25-50 mg 2 x dly in div. doses. Incr.
    intervals at least 2 wks: 100-150 mg dly in div. doses to reach target BP.
    Heart fail.: Init.: 12.5 mg BID or TID.
    Titrat. to maint. dose (75-150 mg dly) at intervals of at least 2 wks. depen. on pt. response.
    Type 1 diabet. nephropathy: 75-100 mg dly in div doses.
    MI, ren. impair., elderly: See lit.
    Hypertens., C.H.F., insulin depend. diabet. nephropathy in hypertens./nonhypertens. pts. when serum creatinine level < 2.5 mg/dl. Improve survival follow. MI in clinic. stable pts. with left ventric. dysfunct. manifest. as eject. fract. < or equals 40% and to reduce incidence of overt heart fail. and subseq. hospitalizat. for C.H.F. in these pts.
    C/I: Hypersens. Hypersens. to other ACE inhib.
    Hist. of angioedema assoc. with previous ACE-inhib. ther., hered. idiopath. angioedema.   2nd, 3rd trim. of preg.
    Concom. use with aliskiren contain. product in pts. with diab. mell. or renal impair. (GFR <60ml/min/1.73 m2). See lit.

    Cilaril
    Unipharm
    RX
    partial basket chart
    Cilaril

    ACE Inhibitor. Cilazapril 1, 2.5, 5 mg.
    TABS: 28 x 1 mg, 2.5 mg, 5 mg. Essent.
    hypertens: 1.25 mg 1 x dly for first 2
    days. Maint: 2.5-10 mg 1 x dly. adjust.
    accord. pt. response. Renovasc. hypertens.
    Initial: 0.5 mg 1 x dly. under close
    med. vision. Maint: Accord. to
    response. C.H.F: Initial: 1 mg dly.
    Maint: 1 - 2.5 mg 1 x dly. Adjust.
    accord. pt. response.
    Essential and renal hypertens., C.H.F.
    C/I: Ascites, pregn., lact.

    Cilaril Plus
    Unipharm
    RX
    partial basket chart
    Multiple ingredients
    Cilaril Plus

    ACE Inhibitor, Thiazide. Cilazapril 5 mg, Hydrochlorothiazide 12.5 mg.
    TABS: 28. 1 tab dly.
    Essential hypertens. in patients who
    have been stabilized on individual
    components given in the same
    proportions.
    C/I: Pregn., lact.

    Enaladex
    Dexcel
    RX
    full basket chart
    Enaladex

    ACE Inhibitor. Enalapril Maleate 5, 10, 20 mg.
    TABS: 30x5mg, 10mg, 20mg. Hypertens.: Initial: usually 5-20 mg 1 x dly. Dose of 5 mg or lower may be indicated in cases such as strongly activated renin-angiotensin-aldosterone syst. prior tmt. with high doses diuretics. See lit. Mainten.: usually 20 mg dly, max. maint. dose: 40 mg dly.
    HF/asymptom. left ventr. dysfunct.: Initial 2.5 mg, incr. gradual.
    Mainten.: 20mg in single dose/2 div. doses. Max: 40mg in 2 div. doses. See lit.
    For dosage in renal insuffic./elderly/paediatrics: see lit.
    Tmt. of essent. hypertens., renovasc. hypertens., CHF, to reduce mortal. in all degrees HF. To retard develop. of symptom. HF In asymptom. pts. with left ventric. dysfunc.
    C/I: Hypersens. Hypersens. to other ACE inhib.; hist. of angioedema assoc. with previous ACE-inhib. ther., hered. idiopath. angioedema; 2nd, 3rd trim. of preg.; concom. use with aliskiren contain. product in pts. with diab. mell. or renal impair. (GFR <60ml/min/1.73 m2); comb. with sacubitril/valsartan.
    Administrat. of enalapril within 36 hrs. of switching to or from sacubitril/valsartan. See lit.

    Enalapri
    CTS
    RX
    full basket chart
    Enalapri

    ACE Inhibitor. Enalapril Maleate 5, 10, 20 mg.
    TABS: 30. See lit.
    Essential hypertens., renovasc.
    hypertens., CCF, reduce mortality in pts.
    with all degrees heart fail., retard
    develop. sympt. heart fail. in asympt. pts.
    with left ventric. dysfunct.

    Ramitens
    Rafa
    RX
    partial basket chart
    Ramitens

    ACE Inhibitor. Ramipril 10 mg.
    CAPS: 10 mg.
    Hypertens., CHF, reduct. mortality aft.
    M.I: Initial. (for pts. not on diuretics):
    2.5 mg 1 x dly. May incr. at intervals of
    2-3 wks. up to 5 mg 1 x dly to max: 10
    mg 1 x dly. Reduct. risk M.I, stroke or
    CV death and/or need for
    revascularizat: Initial: 2.5 mg 1 x dly.
    Depend. On tolerabil. grad. incr. to
    double after approx. 1 wk; aft. further
    3 wks. incr. to 10 mg. Maint: 10 mg 1 x
    dly. Pts already stabilized on lower
    doses for other indicats., where
    possible should be titrated to 10 mg 1
    x dly.
    Hypertens. congest. heart fail., reduct.
    mortality aft. M.I. with left ventric.
    dysfunct., reduce risk M.I., stroke, CV
    death, need for revascularizat. in pts. over
    55 yrs who have clinical evidence of CV
    dis. (prev. M.I., unstable angina,
    multivessel CABG or PTCA), stroke or
    periph. vasc. dis. Also for reducing risk of
    M.I., stroke, CV death or need for
    revascularizat. procedures in diabet. pts of
    55 yrs or more who have one or more of
    the foll. clin. findings: hypertens. (systol.
    pressure >160 mm Hg or diastol. pressure
    >90 mm Hg); high total cholesterol (>5.2
    mmol/L); low HDL (<0.9 mmol/L); current
    smoker; known microalbuminur.; clin.
    evidence of prev. vasc. dis., prevent.
    progress. ren. fail. in pts. suffer. from
    impair. ren. funct

    CLOSE